Skip to main content

Table 6 Molecular interaction of thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) against histone deacetylase (HDAC3) (target site PDB ID: 4A69-A)

From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

  

Thymoquinone (TQ)

Piperine (PIP)

Sorafenib (SOR)

Total

Favorable

8

3

15

Halogen

0

0

2

Hydrophobic

8

0

9

Hydrogen

0

3

4

Favorable

A: GLN52

0

1

0

A: VAL73

0

1

0

A: GLY91

0

0

1

A: ASP93

0

0

2

A: PRO95

0

0

1

A: VAL96

0

0

1

A: LEU100

0

1

0

A: PHE144

2

0

1

A: HIS172

0

0

4

A: PHE199

2

0

1

A: PHE200

2

0

1

A: LEU233

2

0

3

Halogen

A: HIS172

0

0

2

Hydrophobic

A: PRO95

0

0

1

A: PHE144

2

0

1

A: HIS172

0

0

2

A: PHE199

2

0

1

A: PHE200

2

0

1

A: LEU266

2

0

3

Hydrogen

A: GLN52

0

1

0

A: VAL73

0

1

0

A: GLY91

0

0

1

A:ASP93

0

0

2

A: VAL96

0

0

1

A: LEU100

0

1

0